GroPep develops novel factors that increase cell growth, as well as manufactures and commercialises them globally in three sectors of the pharmaceutical industry.

Biotron is an Australian leader in biotechnology research. It funds, manages and commercialises diagnostic & therapeutic research projects ...

Eiffel Technologies undertakes biomedical drug re-engineering using supercritical fluid (SCF) technology platforms to create to sub-micron particles with innovative particle architecture providing improved solubility and bioavailability, for enhanced drug design and delivery.

Combining innovative chemical technologies with sound engineering principals for the environmental cleanup of odor and effluent ...